PULMONARY TOXICITY IN STAGE III NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH HIGH-DOSE (74 GY) 3-DIMENSIONAL CONFORMAL THORACIC RADIOTHERAPY AND CONCURRENT CHEMOTHERAPY FOLLOWING INDUCTION CHEMOTHERAPY: A SECONDARY ANALYSIS OF CANCER AND LEUKEMIA GROUP B (CALGB) TRIAL 30105
Article